NCT05655390

Brief Summary

The goal of this clinical trial is to assess the effectiveness of an original intervention 'Functional Recovery in Depression and Suicide Risk Prevention Based on Emotion Regulation and Values: A Group Program' (from the original Spanish version: Programa Grupal De Recuperación Funcional En Depresión Y Prevención De Riesgo Suicida Basado En Regulación Emocional Y Valores) in depressed patients who have recently attempted suicide by improving their psychosocial functioning and therefore enhancing their ability to perform activities of daily living. As secondary objectives, the effectiveness of the intervention will be evaluated by determining cognitive performance (particularly decision-making, inhibition, and attention), quality of life, clinical status, and their relationship with neuroimaging correlates. Main target neuroimaging areas include the orbitofrontal cortex and dorsal prefrontal cortex.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Sep 2025

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Sep 2025Oct 2027

First Submitted

Initial submission to the registry

October 25, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 19, 2022

Completed
2.7 years until next milestone

Study Start

First participant enrolled

September 16, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

May 12, 2026

Status Verified

May 1, 2026

Enrollment Period

1.5 years

First QC Date

October 25, 2022

Last Update Submit

May 8, 2026

Conditions

Keywords

suicidecognitionneuroimagingpsychosocial functioningquality of life

Outcome Measures

Primary Outcomes (1)

  • Psychosocial functioning changes in Functioning Assessment Short Test (FAST).

    SA+Dep receiving the RECONCILE Intervention will show a decrease in FAST scores, compared to those SA+Dep receiving TAU. Lower general scores on this scale indicate better psychosocial functioning.

    Baseline; 3 months after intervention (short assessment form); 12 months after intervention (full assessment)

Secondary Outcomes (8)

  • Cognitive changes in executive functions, specifically in decision-making measured by the modified version of the Iowa Gambling Task (IGT) with functional Magnetic Resonance (fMRI).

    Baseline; 12 months after intervention

  • Cognitive changes in executive functions, specifically in impulsivity measured by Stroop Test (Stroop).

    Baseline, 3 months after intervention (short assessment form); 12 months after intervention (full assessment).

  • Cognitive changes in executive functions, specifically in attention measured by Conners' Performance Test (CPT-III).

    Baseline; 3 months after intervention (short assessment form); 12 months after intervention (full assessment).

  • Changes in self-reported quality of life by Quality of Life 5-Dimensions scale (EuroQoL-5D).

    Baseline, 3 months after intervention (short assessment form); 12 months after intervention (full assessment).

  • Clinical changes in suicidal behavior assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS).

    Baseline; 3 months after intervention (short assessment form); 12 months after intervention (full assessment).

  • +3 more secondary outcomes

Study Arms (2)

Treatment As Usual

NO INTERVENTION

(TAU)

Intervention Group

EXPERIMENTAL

Treatment As Usual + RECONCILE Psychological Intervention.

Behavioral: 'Functional Recovery in Depression and Suicide Risk Prevention Based on Emotion Regulation and Values: A Group Program'

Interventions

The RECONCILE psychological intervention, a structured telematic group program integrating components mainly from ACT, but also CBT, DBT, psychoeducation, and the collaborative construction of the Safety Planning Intervention (SPI). The aim of this therapy is to help individuals acquire strategies to regulate emotions, improve decision-making and daily functioning, and reduce the risk of suicidal behavior. The SPI will be conducted by identifying warning signs and providing each individual with personalized coping strategies and sources of support. Main skills to be acquired and integrated for the individual are: 1) SPI by six steps (identification of warning signs; applying internal coping strategies; use of social contacts as distraction; contacting family or significant others; contacting professionals and emergency services; making the environment safer), 2) Mindfulness, 3) Distress tolerance, 4) Emotional regulation, and 5) Values-based decision-making and behavioral activation.

Also known as: The original Spanish name: Programa Grupal De Recuperación Funcional En Depresión Y Prevención De Riesgo Suicida Basado En Regulación Emocional Y Valores, RECONCILE Psychological Intervention
Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years old
  • Having attempted suicide
  • Provide written informed consent
  • No claustrophobia/metallic objects/implants

You may not qualify if:

  • Intelligence quotient below 70 and impaired functioning
  • Any medical condition that could affect neuropsychological performance (such as neurological diseases) or a history of head trauma with loss of consciousness
  • Participation in any structured psychological intervention within the past 6 months
  • Patients who received electroconvulsive therapy within the past 6 months
  • Inability to give inform consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hospital Clínic Barcelona

Barcelona, Barcelona, 08036, Spain

RECRUITING

Hospital del Mar

Barcelona, Spain

RECRUITING

Hospital Clínico San Carlos

Madrid, Spain

RECRUITING

Hospital Gregorio Marañón

Madrid, Spain

RECRUITING

Related Publications (1)

  • Roberto N, Vazquez M, Radua J, Pariente JC, Munoz-Moreno E, Laredo C, Bracco L, Fernandez T, Martin-Parra S, Martinez-Aran A, Sanchez-Moreno J, Saiz P, Ruiz-Veguilla M, Borras R, Toll A, Elices M, Brambilla P, Courtet P, Perez-Sola V, Vieta E, Grande I. Safety intervention for improving functioning in suicidal attempters (STRONG): A secondary prevention study. Study rationale and research protocol. Span J Psychiatry Ment Health. 2026 Jan-Mar;19(1):66-72. doi: 10.1016/j.sjpmh.2023.05.001. Epub 2023 Aug 25.

MeSH Terms

Conditions

Suicide, AttemptedSuicide

Interventions

Recovery of Function

Condition Hierarchy (Ancestors)

Self-Injurious BehaviorBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Biological Phenomena

Study Officials

  • Iria Grande

    IDIBAPS- Hospital Clinic de Barcelona

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Experimental randomized clinical study. Rater-blinded. Sample: Suicidal attempters.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

October 25, 2022

First Posted

December 19, 2022

Study Start

September 16, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

May 12, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

Data will be shared only under a justified request. Names and personal data will never be displayed or shared with third parties. The data will be collected in an information file owned by the center. The research team undertakes to preserve the privacy of patients and the confidentiality of data, in accordance with the Organic Law 3/2018, 5th December, about Personal Data Protection. In case of transfer of data to third parties (external promoter to the center) these will be transferred in an encrypted system, eliminating any data that could identify the patient. Only the principal investigator and her team will have access to the list of patient identification codes.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
When approved by the PI. For a period of 6 months at maximum.
Access Criteria
Only coded data will be transferred to third parties and to other countries, which in no case will contain information that can directly identify the participant (such as name and surname, initials, address, social security number, etc.). In the event of such a transfer, it would be for the same purpose of the study described above and guaranteeing confidentiality.

Locations